– Introducing Alzheimer’s illness associated mind picture evaluation know-how together with Neurophet AQUA and Neurophet SCALE PET
– Plans to launch evaluation know-how for toddler mind picture and cerebrovascular illness
SEOUL, South Korea, Nov. 23, 2023 /PRNewswire/ — Neurophet, a man-made intelligence (AI) resolution firm for mind illness, introduced on the twenty third that Neurophet would take part within the Radiological Society of North America 2023 (RSNA 2023). Neurophet plans to share the achievements of mind picture evaluation know-how associated to dementia remedies ready over the previous yr.
Neurophet will showcase flagship merchandise, mind MRI evaluation software program “Neurophet AQUA” and mind PET scan evaluation software program “Neurophet SCALE PET”. Through the onsite demonstration, attendees may expertise AI-powered mind picture evaluation know-how, which shall be launched sooner or later equivalent to evaluation of Alzheimer’s illness remedy unintended effects.
Alzheimer’s illness remedies equivalent to Leqembi, absolutely authorized by the U.S. Food and Drug Administration (FDA) this yr, are new medication that cut back beta-amyloid proteins within the mind. ARIA (Amyloid-Related Imaging Abnormalities) unintended effects can happen whereas taking the medication, and the signs embrace edema and hemorrhages. Neurophet plans to launch ARIA evaluation product subsequent yr and can introduce the know-how on the sales space as effectively.
Neurophet is about to current at AI Theater and Scientific Poster Session primarily based on the research of mind evaluation know-how associated to Alzheimer’s illness. The medical director of Neurophet will give displays on the subject of “How to be Prepared for the Real-World Amyloid Target Drug Prescriptions: ARIA, Amyloid Positivity and Beyond” at AI Theater.
The different research “White Matter Lesion Asymmetry-An Indicator of Amyloid PET Positivity in Mild Cognitive Impairment Patients” shall be introduced on the Scientific Poster Session.
“Neurophet ready demonstrations of varied applied sciences to research toddler mind picture and cerebrovascular illness, which shall be launched sooner or later along with Alzheimer’s illness at RSNA” mentioned CEO Jake Junkil Been of Neurophet. “Based on Neurophet’s mind picture evaluation know-how encompassing the whole mind illness, we are going to intensify our efforts in gross sales and advertising and marketing to result in significant business outcomes.”
The RSNA, celebrating its 109th anniversary this yr, is the world’s largest radiology society, attracting specialists and officers from academia, drugs, and business worldwide to share the latest research and achievements. RSNA takes place in Chicago, USA yearly, which begins this yr on the twenty sixth (native time) and runs till the thirtieth.
About Neurophet
Neurophet has specialised in creating options for analysis assist, remedy guides, and remedy gadgets concentrating on mind illnesses primarily based on cutting-edge synthetic intelligence (AI) know-how. The firm was based in 2016 by Jake Junkil Been, CEO, and Donghyeon Kim, CTO, who developed the next-generation neuro-navigation system.
Major merchandise embrace mind MRI evaluation software program “Neurophet AQUA”, mind PET scan evaluation (PET tracer deposition) software program “Neurophet SCALE PET”, mind imaging remedy planning software program for electrical and magnetic mind stimulation “Neurophet tES/TMS LAB”, and cloud-based mind imaging evaluation analysis instrument “Neurophet SegPlus”.
Neurophet has set its high precedence to serving to sufferers affected by mind illnesses. Based on experience in neuroscience, Neurophet will proceed to problem and develop to discover the human mind’s well being and pioneer options for mind illnesses with AI know-how.
View authentic content material to obtain multimedia:https://www.prnewswire.com/news-releases/neurophet-to-showcase-brain-image-analysis-technology-at-rsna-2023-301996336.html
SOURCE Neurophet
